Loading clinical trials...
Loading clinical trials...
This is a multicenter, long-term, follow-up trial of participants with Gaucher disease type 1 who received FLT201 treatment in a preceding clinical trial. Participants will be followed for 5 years pos...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Spur Therapeutics
NCT05487599 · Gaucher Disease, Gaucher Disease, Type 1
NCT05253560 · Gaucher Disease, Type 1, Healthy
NCT04353466 · Gaucher Disease, Type 1
NCT04120506 · Gaucher Disease, Type 1
NCT00430625 · Gaucher Disease, Type 1
Lysosomal Rare Disorders Research and Treatment Center
Fairfax, Virginia
Hospital de Clinicas de Porto Alegre (HCPA)
Porto Alegre
Hospital Quironsalud Zaragoza
Zaragoza
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions